James E. Monroe - Concepedia

Author

James E. Monroe

University of Massachusetts Chan Medical School

Also Known As

J E Monroe, J. E. Monroe, James E. Monroe, James Monroe, James. Monroe

Publications

668

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School National Health Laboratory Service University of Cape Town Novartis (United States)Groote Schuur Hospital

About

James E. Monroe is an author at University of Massachusetts Chan Medical School specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	404
2	Cell Biology	3	3	134
3	Natural Sciences	2	2	26
4	Biochemistry	1	1	11
5	Biomolecular Engineering	1	1	94

James E. Monroe

Publications

662

Citations

H-Index

Page 1

	Year	Citations
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody Sumana Chandramouli, Claudio Ciferri, Pavel A. Nikitin, Nature Communications	2015	133
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) Aurelio Bonavia, Michael Franti, Erin P. Keaney, Proceedings of the National Academy of Sciences Novel Therapeutic InterventionsMedicinal ChemistryRespiratory Syncytial VirusViral DiseaseSynthetic Virology	2011	94
Epstein–Barr-Virus Induced Lymphoproliferation John L. Sullivan, Peter G. Medveczky, Stephen J. Forman, New England Journal of Medicine ImmunodeficienciesImmunologyPathologyImmunotherapyHuman Retrovirus	1984	89
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice Yingxia Wen, James E. Monroe, Christine Linton, Vaccine Autoimmune DiseaseImmunologyAntiviral ResponseImmunologic MechanismAutoimmunity	2014	78
Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2 James E. Monroe, Alain Calender, Carel Mulder Journal of Virology Primary ImmunodeficiencyHuman Immunodeficiency VirusViral PersistenceMolecular VirologyEpstein-barr Virus	1988	48
Construction, Characterization, and Immunogenicity of a Multigene Modified Vaccinia Ankara (MVA) Vaccine Based on HIV Type 1 Subtype C Wendy A. Burgers, Enid Shephard, James E. Monroe, AIDS Research and Human Retroviruses	2008	47
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies Rebecca J. Loomis, Anders Lilja, James E. Monroe, Vaccine VaccinationImmunologyAntiviral ResponseTherapeutic VaccineVirology	2012	41
Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV Ann‐Muriel Steff, James E. Monroe, Kristian Friedrich, Nature Communications	2017	39
A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice Enid Shephard, Wendy A. Burgers, Joanne H. van Harmelen, AIDS Research and Human Retroviruses	2008	29
Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication Masanori Daibata, Eva-Maria Enzinger, James E. Monroe, Antiviral Research Viral ReplicationNatural SciencesImmunologyAntiviral ResponseDna Replication	1996	15

Page 1